Hyperliquid didn’t rely on hype cycles or marketing blitzes to break into the spotlight—it engineered its way into relevance, forcing the crypto industry to reassess how far onchain trading infrastructure…

Hyperliquid Strategies Inc. (HSI), formed from an $888 million reverse merger between Sonnet Biotherapeutics Holdings Inc. and Rorschach I LLC, has filed a Form S-1 registration with the U.S. Securities…